Skip to main content

Travel Medicine

RSS  

Articles

  • Nodding Syndromein South Sudan

    In May 2011, an emergency-response team from the US Centers for Disease Control and Prevention (CDC) traveled to South Sudan, attempting to assist in the investigation of the recent geographic clustering of an illness, suspected to be the nodding syndrome.
  • Pharmacology Update: Critical Drug Shortages Are on the Rise

    In this issue: Drug shortages; metformin and cancer prevention; migraine prevention guidelines; and FDA actions.
  • Moxifloxacin for Odontogenic Infection

    Outpatients with a diagnosis of either dentoalveolar or periodontal abscess or a diagnosis of gingival inflammatory infiltrates were randomized to receive either moxifloxacin 400 mg daily or clindamycin 300 mg QID, both for 5 days, in a prospective, randomized, placebo-controlled, double-dummy clinical trial design.
  • Seaweed Poultices and Vibrio Infection

    This report details the occurrence of an infected, cellulitic lower extremity wound infection in a 70-year-old British woman secondary to an unusual Vibrio species, V. alginolyticus.
  • The Globalization of Antibiotic Resistance — India and Cambodia

    During November, 2011, I attended separate meetings dedicated to exploring the incidence of antimicrobial resistance in two areas of the developing world, India and Cambodia. The first, sponsored jointly by the American Society for Microbiology (ASM), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and the Indian Association of Medical Microbiologists (IAMM), was named the "International Workshop on Antimicrobial Resistance" and was held at the Haffkine Institute in Mumbai, India. Organized by Prof. Lance Peterson (ASM representative), Prof. Abhay Chowdhary (Director of Haffkine Institute), Prof. V. Ravi (President of the IAMM), and Prof. Guiseppe Cornaglia (President of ESCMID), the workshop brought together around 250 participants, principally from India, to discuss various aspects of antimicrobial resistance over a 2.5 day program.
  • Norovirus bounces between NBA players

    Beginning in November 2010, players from several NBA teams were reported as suffering from the "stomach flu". An investigation was launched, querying 400 players and 378 staff members whether they had experienced nausea and/or vomiting sometime between November 10 and December 20. In total, 21 players and 3 staff members met the case definition for acute gastroenteritis from norovirus, based on the presence of symptoms with or without a positive RT-PCR stool test for norovirus. These 24 individuals represented 13 different teams from 11 different states.
  • Childproof: Meningococcal Vaccine for Very Young At-Risk Travelers

    The Advisory Committee on Immunization Practices (ACIP) set forth new guidelines in October 2011 for the use of a quadrivalent meningococcal conjugate vaccine (MenACWY-D) in children, ages 9 to 23 months, that are at increased risk for meningococcal disease.
  • Advice Ignored on Acute Mountain Sickness

    Acute mountain sickness (AMS) is a syndrome that can affect travelers who are not acclimatized and gain altitude too quickly, usually occurring above 2,500 m. (8,200 ft.) elevation.
  • Isoniazid and Rifapentine for Treatment of Latent Tuberculosis

    In this report, the new CDC recommendations for the concomitant use of isoniazid (INH) and rifapentine (RPT) administered weekly for 12 weeks as directly observed therapy (DOT) are detailed.
  • Pharmacology Watch: New, Shorter Treatment Regimen for Tuberculosis

    In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.